The primary aim of this study is to determine if patients with SLE produce an antibody response to the hepatitis B vaccination series similar to that of normal controls. In addition, this study will also evaluate the kinetics of the hepatitis B antibody response, determine the incidence of adverse reactions to the vaccine in lupus patients and document lupus flares in the vaccinated population.
Showing the most recent 10 out of 1065 publications